Manufacturer record
Intas Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Intas Pharmaceuticals Ltd (Sikkim) were declared Not of Standard Quality between November 2019 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: N2601077, Levetiracetam Tablets IP 500 mg (exp Mar 2029). LUCKNOW, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to IP with respect to Dissolution and The sample does not meet the labelling requrements of IP 2022 and Rules 96. Listed in the September 2026 alert.
Records by type
11 records linked to Intas Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levetiracetam Tablets IP 500 mg | Batch N2601077Mfg Apr 2026 · Exp Mar 2029 | The sample does not conform to IP with respect to Dissolution and The sample does not meet the labelling requrements of IP 2022 and Rules 96 (IV) of the D & C Rules 1945, Hence MisbrandedDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Levetiracetam Tablets IP 500 mg | Batch N2600803Mfg Mar 2026 · Exp Feb 2029 | The sample does not conform to IP in respect of Dissolution.Dissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Levetiracetam Tablets IP 500 mg | Batch N2601623Mfg May 2026 · Exp Apr 2029 | The sample does not conform to IP with respect to Dissolution and The sample does not meet the labelling requrements of the D & C Act 1940 and Rules thereunder, Hence MisbrandedDissolution | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Rabeprazole Sodium Tablets IP 20 mg | Batch N2600742Mfg Mar 2026 · Exp Feb 2028 | The sample does not conform to claim as per IP 2022 and Addendum 2024 in respect to the Test of Dissolution (Buffer Stage).Dissolution | RDTL, ChandigarhCDSCO lab | Aug 2026 |
| Pantoprazole Tablets IP 40mg. | Batch N2501055Mfg Mar 2025 · Exp Feb 2028 | The sample does not conform to I.P with respect to the test for "Dissolution in Buffer Stage:.Dissolution | CDTL,IndoreCDSCO lab | Nov 2025 |
| Amlodipine and Perindopril Tablets (Amtas PRP) | Batch K2201310Mfg Jun 2022 · Exp May 2025 | Assay of Perindopril ErbumineAssay | CDL KolkataCDSCO lab | Oct 2024 |
| Bisoprolol Fumarate Tablets USP 2.5 mg (BISELECT 2.5) | Batch V2300382Mfg Apr 2023 · Exp Mar 2025 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Oct 2023 |
| AMTAS PRP (Amlodipine and Perindopril Tablets) | Batch K2200008 2Mfg Jan 2022 · Exp Dec 2024 | Assay of Perindopril ErbumineAssay | CDL KolkataCDSCO lab | Aug 2023 |
| Amtas PRP (Amlodipine And Perindopril Tablets) | Batch K2102200Mfg Oct 2021 · Exp Sep 2024 | Perindopril Erbumine AssayAssay | CDTL MumbaiCDSCO lab | Feb 2023 |
| DOXIN - 75 (Doxepin Hydrochloride Capsules I.P. 75 mg) | Batch NW2013Mfg Dec 2017 · Exp Nov 2020 | Description and AssayAssay | CDL KolkataCDSCO lab | May 2020 |
| Rabiun-DSR (Enteric coated Rabeprazole Sodium and Domperidon SR Capsules) | Batch NY1180Mfg May 2019 · Exp Apr 2021 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Nov 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.